Paysign CPO reports modest share sale following 64k RSU exercise
Rhea-AI Filing Summary
Paysign, Inc. (PAYS) Form 4: Chief Payments Officer & Director Matthew Lanford reported two transactions. On 31-Jul-2025 he vested and acquired 64,000 common shares at a $0.00 exercise price from a 2022 restricted-stock grant (one-fifth vests annually through 31-Jul-2027). On 04-Aug-2025 he sold 26,367 shares on the open market at a weighted-average $7.0851 (range $6.9976-$7.1530). After these trades he directly owns 147,364 common shares and holds 128,000 unvested/derivative shares under the same grant. The filing was submitted as a single-person report and is not 10b5-1 designated.
Positive
- Officer retains a sizeable stake of 147,364 shares plus 128,000 unvested RSUs, suggesting ongoing alignment with shareholders.
Negative
- Discretionary sale of 26,367 shares (~$187k) could be interpreted as reduced short-term confidence.
- No 10b5-1 plan cited, so market may read timing as opportunistic rather than pre-scheduled.
Insights
TL;DR: Small insider sale after vesting; ownership remains large—signal modestly negative but low impact.
The officer exercised zero-cost RSUs, then sold ~41% of the acquired shares, realising ~$187k in proceeds. He retains >147k shares plus 128k unvested RSUs, implying continued alignment. Transaction size is immaterial versus Paysign’s ~54 M share float and does not indicate a broad shift in insider sentiment. No 10b5-1 plan disclosed, so timing is discretionary. Overall market impact should be minimal, but investors may view the discretionary sale as a mild negative momentum signal.
Insider Trade Summary
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Sale | Common Stock | 26,367 | $7.0851 | $187K |
| Exercise | Stock Grant | 64,000 | $0.00 | -- |
| Exercise | Common Stock | 64,000 | $0.00 | -- |
Footnotes (1)
- One-fifth of the restricted stock shall vest annually on each anniversary of the July 31, 2022 vesting commencement date until fully vested on July 31, 2027. The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $6.9976 to $7.1530, inclusive. The reporting person undertakes to provide to Paysign, Inc. (the "Company"), any security holder of the Company, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
